全球荷尔蒙替代疗法市场研究报告 - 2023 年至 2030 年行业分析、规模、份额、成长、趋势和预测

预计到 2030 年，全球荷尔蒙替代疗法市场的市场规模将从 2022 年的 236.8 亿美元达到近 455.5 亿美元，2023-2030 年研究期间复合年增长率为 8.52%。

荷尔蒙替代疗法（HRT）是一种用于治疗更年期问题的女性的疗法。与人体正常生理所需的水平相比，此类患者的和谐水平不足。荷尔蒙替代疗法可以改善并延长许多老年女性的寿命，无论是在更年期或更晚的时候开始。荷尔蒙替代疗法可以帮助老年女性维持雌激素水平。

市场动态：

女性更年期不适的激增和对停经后问题认识的提高预计将在很大程度上影响荷尔蒙替代疗法市场的成长。老年人口的增长是造成这种疗法需求量大的另一个原因。同时，新的荷尔蒙替代疗法产品的推出预计将推动市场成长。此外，药物输送系统的技术创新也可能对未来几年的荷尔蒙替代疗法市场产生正面影响。此外，人们对荷尔蒙替代疗法认识的提高预计也将推动市场成长。然而，与荷尔蒙替代疗法相关的高价格可能会阻碍市场成长。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具还对全球荷尔蒙替代疗法市场的每个细分市场进行了包容性评估。荷尔蒙替代疗法产业的成长和趋势为本研究提供了整体方法。

区域分析：

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲荷尔蒙替代疗法市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。荷尔蒙替代疗法市场的主要参与者包括拜耳公司、辉瑞公司、默克公司、Viatris公司、诺和诺德公司、礼来公司、罗氏公司、诺文製药公司., ASCEND Therapeutics US LLC., AbbVie Inc.本部分包含竞争格局的整体视图，其中包括各种策略发展，例如关键併购、未来产能、合作伙伴关係、财务概览、合作、新产品开发、新产品发射和其他进展。

如果您有任何客製化要求，请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

目录

第一章：前言

• 报告说明
  • 客观的
  • 目标受众
  • 独特的销售主张 (USP) 和产品
• 研究范围
• 研究方法论
  • 市场研究过程
  • 市场研究方法论

第 2 章：执行摘要

• 市集亮点
• 全球市场概况

第 3 章：荷尔蒙替代疗法 - 产业分析

• 简介 - 市场动态
• 市场驱动因素
• 市场限制
• 机会
• 产业动态
• 波特五力分析
• 市场吸引力分析
  • 按产品分類的市场吸引力分析
  • 按给药途径进行的市场吸引力分析
  • 按疾病类型分類的市场吸引力分析
  • 市场吸引力分析：按地区

第 4 章：价值链分析

• 价值链分析
• 原料分析
  • 原料清单
  • 原料厂商清单
  • 主要原物料价格走势
• 潜在买家名单
• 行销管道
  • 直效行销
  • 间接行销
  • 行销通路发展趋势

第 5 章：COVID-19 爆发的影响分析

第 6 章：全球荷尔蒙替代疗法市场分析：按产品

• 按产品概述
• 历史和预测数据
• 按产品分析
• 雌激素和黄体酮替代疗法
• 人类生长激素 (HGH) 替代疗法
• 甲状腺激素替代疗法
• 睾酮替代疗法
• 副甲状腺素替代疗法

第 7 章：全球荷尔蒙替代疗法市场分析：按给药途径

• 依给药途径概述
• 历史和预测数据
• 依给药途径分析
• 口服
• 注射用
• 透皮
• 其他的

第 8 章：全球荷尔蒙替代疗法市场销售分析：按疾病类型

• 依疾病类型概述
• 历史和预测数据
• 依疾病类型分析
• 停经
• 甲状腺功能低下症
• 男性性腺功能减退症
• 生长激素缺乏
• 副甲状腺功能减退症

第 9 章：全球荷尔蒙替代疗法市场销售分析：按地理位置

• 区域展望销售分析
• 简介 销售分析
• 北美销售分析
  • 概述、历史和预测销售分析
  • 北美按细分市场销售分析
  • 北美按国家销售分析
  • 美国销售分析
  • 加拿大销售分析
  • 墨西哥销售分析
• 欧洲销售分析
  • 概述、历史和预测销售分析
  • 欧洲按细分市场销售分析
  • 欧洲按国家销售分析
  • 英国销售分析
  • 法国销售分析
  • 德国销售分析
  • 义大利销售分析
  • 俄罗斯销售分析
  • 欧洲其他地区销售分析
• 亚太地区销售分析
  • 概述、历史和预测销售分析
  • 亚太地区按细分市场销售分析
  • 亚太地区国家/地区销售分析
  • 中国销售分析
  • 印度销售分析
  • 日本销售分析
  • 韩国销售分析
  • 澳洲销售分析
  • 亚太地区其他地区销售分析
• 拉丁美洲销售分析
  • 概述、历史和预测销售分析
  • 拉丁美洲按细分市场销售分析
  • 拉丁美洲按国家销售分析
  • 巴西销售分析
  • 阿根廷销售分析
  • 秘鲁销售分析
  • 智利销售分析
  • 拉丁美洲其他地区销售分析
• 中东和非洲销售分析
  • 概述、历史和预测销售分析
  • 中东和非洲按细分市场销售分析
  • 中东和非洲国家销售分析
  • 沙乌地阿拉伯销售分析
  • 阿联酋销售分析
  • 以色列销售分析
  • 南非销售分析
  • 中东其他地区和非洲销售分析

第 10 章：荷尔蒙替代疗法公司的竞争格局

• 荷尔蒙替代疗法市场竞争
• 伙伴关係/协作/协议
• 併购
• 新产品发布
• 其他发展

第 11 章：公司简介

• 十大公司股票分析
• 市场集中度
• Bayer AG
• 公司简介
• 公司收入
• 产品
• 最近的发展
• Pfizer Inc.
• 公司简介
• 公司收入
• 产品
• 最近的发展
• Merck & Co. Inc.
• 公司简介
• 公司收入
• 产品
• 最近的发展
• Viatris Inc.
• 公司简介
• 公司收入
• 产品
• 最近的发展
• Novo Nordisk A/S
• 公司简介
• 公司收入
• 产品
• 最近的发展
• Eli Lilly and Company
• 公司简介
• 公司收入
• 产品
• 最近的发展
• F. Hoffmann-La Roche Ltd
• 公司简介
• 公司收入
• 产品
• 最近的发展
• Noven Pharmaceuticals Inc.
• 公司简介
• 公司收入
• 产品
• 最近的发展
• ASCEND Therapeutics US LLC.
• 公司简介
• 公司收入
• 产品
• 最近的发展
• AbbVie Inc.
• 公司简介
• 公司收入
• 产品
• 最近的发展

注意 - 在公司概况中，财务详细资讯和近期发展视情况而定，或者如果是私人公司，则可能不包括在内

The global demand for Hormone Replacement Therapy Market is presumed to reach the market size of nearly USD 45.55 BN by 2030 from USD 23.68 BN in 2022 with a CAGR of 8.52% under the study period 2023 - 2030.

Hormone replacement therapy (HRT) is a therapy used to treat women suffering from menopause issues. The harmones in such pateints are at inadequate levels compared to those required for the normal physiology of the human body. Hormone replacement therapy improves and extends the lives of many older women, whether initiated at menopause or much later. Hormone replacement therapy helps older women maintain their estrogen levels.

MARKET DYNAMICS:

A surge in menopausal discomfort and increased awareness about post-menopausal issues among women are expected to influence the hormone replacement therapy market growth to a great extent. The growth in the geriatric population is another reason for high demand of this therapy. Along with this, the launch of new hormone replacement therapy products is anticipated to drive market growth. Furthermore, the technological innovations in drug delivery systems could also positively impact the hormone replacement therapy market in the next few years. In addition, increased awareness about hormone replacement therapy is also expected to drive market growth. However, the high price associated with hormonal replacement therapy treatment may hamper the market growth.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of hormone replacement therapy. The growth and trends of hormone replacement therapy industry provide a holistic approach to this study.

MARKET SEGMENTATION:

This section of the hormone replacement therapy market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

• Estrogen And Progesterone Replacement Therapy
• Human Growth Hormone (HGH) Replacement Therapy
• Thyroid Hormone Replacement Therapy
• Testosterone Replacement Therapy
• Parathyroid Hormone Replacement

By Route Of Administration

• Oral
• Parenteral
• Transdermal
• Others

By Disease Type

• Menopause
• Hypothyroidism
• Male Hypogonadism
• Growth Hormone Deficiency
• Hypoparathyroidism

REGIONAL ANALYSIS:

This section covers the regional outlook, which accentuates current and future demand for the Hormone Replacement Therapy market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the hormone replacement therapy market include Bayer AG, Pfizer Inc., Merck & Co. Inc., Viatris Inc., Novo Nordisk A/S, Eli Lilly and Company, F. Hoffmann-La Roche Ltd, Noven Pharmaceuticals Inc., ASCEND Therapeutics US LLC., AbbVie Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

• 1.1. Report Description
  • 1.1.1. Objective
  • 1.1.2. Target Audience
  • 1.1.3. Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1. Market Research Process
  • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3 . HORMONE REPLACEMENT THERAPY - INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porter's Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Product
  • 3.7.2 Market Attractiveness Analysis By Route Of Administration
  • 3.7.3 Market Attractiveness Analysis By Disease Type
  • 3.7.4 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1. List of Raw Materials
  • 4.2.2. Raw Material Manufactures List
  • 4.2.3. Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1. Direct Marketing
  • 4.4.2. Indirect Marketing
  • 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

6 . GLOBAL HORMONE REPLACEMENT THERAPY MARKET ANALYSIS BY PRODUCT

• 6.1 Overview by Product
• 6.2 Historical and Forecast Data
• 6.3 Analysis by Product
• 6.4 Estrogen and Progesterone Replacement Therapy Historic and Forecast Sales by Regions
• 6.5 Human Growth Hormone (HGH) Replacement Therapy Historic and Forecast Sales by Regions
• 6.6 Thyroid Hormone Replacement Therapy Historic and Forecast Sales by Regions
• 6.7 Testosterone Replacement Therapy Historic and Forecast Sales by Regions
• 6.8 Parathyroid Hormone Replacement Historic and Forecast Sales by Regions

7 . GLOBAL HORMONE REPLACEMENT THERAPY MARKET ANALYSIS BY ROUTE OF ADMINISTRATION

• 7.1 Overview by Route Of Administration
• 7.2 Historical and Forecast Data
• 7.3 Analysis by Route Of Administration
• 7.4 Oral Historic and Forecast Sales by Regions
• 7.5 Parenteral Historic and Forecast Sales by Regions
• 7.6 Transdermal Historic and Forecast Sales by Regions
• 7.7 Others Historic and Forecast Sales by Regions

8 . GLOBAL HORMONE REPLACEMENT THERAPY MARKET SALES ANALYSIS BY DISEASE TYPE

• 8.1 Overview by Disease Type
• 8.2 Historical and Forecast Data
• 8.3 Analysis by Disease Type
• 8.4 Menopause Historic and Forecast Sales by Regions
• 8.5 Hypothyroidism Historic and Forecast Sales by Regions
• 8.6 Male Hypogonadism Historic and Forecast Sales by Regions
• 8.7 Growth Hormone Deficiency Historic and Forecast Sales by Regions
• 8.8 Hypoparathyroidism Historic and Forecast Sales by Regions

9 . GLOBAL HORMONE REPLACEMENT THERAPY MARKET SALES ANALYSIS BY GEOGRAPHY

• 9.1. Regional Outlook Sales Analysis
• 9.2. Introduction Sales Analysis
• 9.3. North America Sales Analysis
  • 9.3.1. Overview, Historic and Forecast Sales Analysis
  • 9.3.2. North America By Segment Sales Analysis
  • 9.3.3. North America By Country Sales Analysis
  • 9.3.4. United State Sales Analysis
  • 9.3.5. Canada Sales Analysis
  • 9.3.6. Mexico Sales Analysis
• 9.4. Europe Sales Analysis
  • 9.4.1. Overview, Historic and Forecast Sales Analysis
  • 9.4.2. Europe by Segment Sales Analysis
  • 9.4.3. Europe by Country Sales Analysis
  • 9.4.4. United Kingdom Sales Analysis
  • 9.4.5. France Sales Analysis
  • 9.4.6. Germany Sales Analysis
  • 9.4.7. Italy Sales Analysis
  • 9.4.8. Russia Sales Analysis
  • 9.4.9. Rest Of Europe Sales Analysis
• 9.5. Asia Pacific Sales Analysis
  • 9.5.1. Overview, Historic and Forecast Sales Analysis
  • 9.5.2. Asia Pacific by Segment Sales Analysis
  • 9.5.3. Asia Pacific by Country Sales Analysis
  • 9.5.4. China Sales Analysis
  • 9.5.5. India Sales Analysis
  • 9.5.6. Japan Sales Analysis
  • 9.5.7. South Korea Sales Analysis
  • 9.5.8. Australia Sales Analysis
  • 9.5.9. Rest Of Asia Pacific Sales Analysis
• 9.6. Latin America Sales Analysis
  • 9.6.1. Overview, Historic and Forecast Sales Analysis
  • 9.6.2. Latin America by Segment Sales Analysis
  • 9.6.3. Latin America by Country Sales Analysis
  • 9.6.4. Brazil Sales Analysis
  • 9.6.5. Argentina Sales Analysis
  • 9.6.6. Peru Sales Analysis
  • 9.6.7. Chile Sales Analysis
  • 9.6.8. Rest of Latin America Sales Analysis
• 9.7. Middle East & Africa Sales Analysis
  • 9.7.1. Overview, Historic and Forecast Sales Analysis
  • 9.7.2. Middle East & Africa by Segment Sales Analysis
  • 9.7.3. Middle East & Africa by Country Sales Analysis
  • 9.7.4. Saudi Arabia Sales Analysis
  • 9.7.5. UAE Sales Analysis
  • 9.7.6. Israel Sales Analysis
  • 9.7.7. South Africa Sales Analysis
  • 9.7.8. Rest Of Middle East And Africa Sales Analysis

10 . COMPETITIVE LANDSCAPE OF THE HORMONE REPLACEMENT THERAPY COMPANIES

• 10.1. Hormone Replacement Therapy Market Competition
• 10.2. Partnership/Collaboration/Agreement
• 10.3. Merger And Acquisitions
• 10.4. New Product Launch
• 10.5. Other Developments

11 . COMPANY PROFILES OF HORMONE REPLACEMENT THERAPY INDUSTRY

• 11.1. Top 10 Company Share Analysis
• 11.2. Market Concentration Rate
• 11.3. Bayer AG
  • 11.3.1. Company Overview
  • 11.3.2. Company Revenue
  • 11.3.3. Products
  • 11.3.4. Recent Developments
• 11.4. Pfizer Inc.
  • 11.4.1. Company Overview
  • 11.4.2. Company Revenue
  • 11.4.3. Products
  • 11.4.4. Recent Developments
• 11.5. Merck & Co. Inc.
  • 11.5.1. Company Overview
  • 11.5.2. Company Revenue
  • 11.5.3. Products
  • 11.5.4. Recent Developments
• 11.6. Viatris Inc.
  • 11.6.1. Company Overview
  • 11.6.2. Company Revenue
  • 11.6.3. Products
  • 11.6.4. Recent Developments
• 11.7. Novo Nordisk A/S
  • 11.7.1. Company Overview
  • 11.7.2. Company Revenue
  • 11.7.3. Products
  • 11.7.4. Recent Developments
• 11.8. Eli Lilly and Company
  • 11.8.1. Company Overview
  • 11.8.2. Company Revenue
  • 11.8.3. Products
  • 11.8.4. Recent Developments
• 11.9. F. Hoffmann-La Roche Ltd
  • 11.9.1. Company Overview
  • 11.9.2. Company Revenue
  • 11.9.3. Products
  • 11.9.4. Recent Developments
• 11.10. Noven Pharmaceuticals Inc.
  • 11.10.1. Company Overview
  • 11.10.2. Company Revenue
  • 11.10.3. Products
  • 11.10.4. Recent Developments
• 11.11. ASCEND Therapeutics US LLC.
  • 11.11.1. Company Overview
  • 11.11.2. Company Revenue
  • 11.11.3. Products
  • 11.11.4. Recent Developments
• 11.12. AbbVie Inc.
  • 11.12.1. Company Overview
  • 11.12.2. Company Revenue
  • 11.12.3. Products
  • 11.12.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

• Market Snapshot
• Drivers : Impact Analysis
• Restraints : Impact Analysis
• List of Raw Material
• List of Raw Material Manufactures
• List of Potential Buyers
• Analysis by Product (USD MN)
• Estrogen and Progesterone Replacement Therapy Market Sales by Geography (USD MN)
• Human Growth Hormone (HGH) Replacement Therapy Market Sales by Geography (USD MN)
• Thyroid Hormone Replacement Therapy Market Sales by Geography (USD MN)
• Testosterone Replacement Therapy Market Sales by Geography (USD MN)
• Parathyroid Hormone Replacement Market Sales by Geography (USD MN)
• Analysis Market by Route Of Administration (USD MN)
• Oral Market Sales by Geography (USD MN)
• Parenteral Market Sales by Geography (USD MN)
• Transdermal Market Sales by Geography (USD MN)
• Others Market Sales by Geography (USD MN)
• Analysis by Disease Type (USD MN)
• Menopause Market Sales by Geography (USD MN)
• Hypothyroidism Market Sales by Geography (USD MN)
• Male Hypogonadism Market Sales by Geography (USD MN)
• Growth Hormone Deficiency Market Sales by Geography (USD MN)
• Hypoparathyroidism Market Sales by Geography (USD MN)
• Global Hormone Replacement Therapy Market Sales by Geography (USD MN)
• North America Market Analysis (USD MN)
• United State Market Analysis (USD MN)
• Canada Market Analysis (USD MN)
• Mexico Market Analysis (USD MN)
• Europe Market Analysis (USD MN)
• Europe Market Estimate by Country (USD MN)
• United Kingdom Market Analysis (USD MN)
• France Market Analysis (USD MN)
• Germany Market Analysis (USD MN)
• Italy Market Analysis (USD MN)
• Russia Market Analysis (USD MN)
• Spain Market Analysis (USD MN)
• Rest of Europe Market Analysis (USD MN)
• Asia Pacific Market Analysis (USD MN)
• China Market Analysis (USD MN)
• Japan Market Analysis (USD MN)
• India Market Analysis (USD MN)
• South Korea Market Analysis (USD MN)
• Australia Market Analysis (USD MN)
• Rest of Asia Pacific Market Analysis (USD MN)
• Latin America Market Analysis (USD MN)
• Brazil Market Analysis (USD MN)
• Argentina Market Analysis (USD MN)
• Peru Market Analysis (USD MN)
• Chile Market Analysis (USD MN)
• Rest of Latin America Market Analysis (USD MN)
• Middle East & Africa Market Analysis (USD MN)
• Saudi Arabia Market Analysis (USD MN)
• UAE Market Analysis (USD MN)
• Israel Market Analysis (USD MN)
• South Africa Market Analysis (USD MN)
• Rest of Middle East and Africa Market Analysis (USD MN)
• Partnership/Collaboration/Agreement
• Mergers And Acquisition

LIST OF FIGURES

• Research Scope of Hormone Replacement Therapy Report
• Market Research Process
• Market Research Methodology
• Global Hormone Replacement Therapy Market Size, by Region (USD MN)
• Porters Five Forces Analysis
• Market Attractiveness Analysis by Product
• Market Attractiveness Analysis by Route Of Administration
• Market Attractiveness Analysis by Disease Type
• Market Attractiveness Analysis by Region
• Value Chain Analysis
• Global Market Analysis by Product (USD MN)
• Estrogen and Progesterone Replacement Therapy Market Sales by Geography (USD MN)
• Human Growth Hormone (HGH) Replacement Therapy Market Sales by Geography (USD MN)
• Thyroid Hormone Replacement Therapy Market Sales by Geography (USD MN)
• Testosterone Replacement Therapy Market Sales by Geography (USD MN)
• Parathyroid Hormone Replacement Market Sales by Geography (USD MN)
• Global Market Analysis by Route Of Administration (USD MN)
• Oral Market Sales by Geography (USD MN)
• Parenteral Market Sales by Geography (USD MN)
• Transdermal Market Sales by Geography (USD MN)
• Others Market Sales by Geography (USD MN)
• Global Market Analysis by Disease Type (USD MN)
• Menopause Market Sales by Geography (USD MN)
• Hypothyroidism Market Sales by Geography (USD MN)
• Male Hypogonadism Market Sales by Geography (USD MN)
• Growth Hormone Deficiency Market Sales by Geography (USD MN)
• Hypoparathyroidism Market Sales by Geography (USD MN)
• Global Market by Revenue
• North America Market by Revenue
• Europe Market by Revenue
• Asia Pacific Market by Revenue
• Latin America Market by Revenue
• Middle East & Africa Market by Revenue
• Recent Development in Industry
• Top Company Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.